Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study von Dienstmann, R., Mason, M.J., Sinicrope, F.A., Phipps, A.I., Tejpar, S., Nesbakken, A., Danielsen, S.A., Sveen, A., Buchanan, D.D., Clendenning, M., Rosty, C., Bot, B., Alberts, S.R., Milburn Jessup, J., Lothe, R.A., Delorenzi, M., Newcomb, P.A., Sargent, D., Guinney, J.

Volltext

Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCEN... von Taieb, J., Shi, Q., Pederson, L., Alberts, S., Wolmark, N., Van Cutsem, E., de Gramont, A., Kerr, R., Grothey, A., Lonardi, S., Yoshino, T., Yothers, G., Sinicrope, F.A., Zaanan, A., André, T.

Volltext

Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance) von Lee, H., Sha, D., Foster, N.R., Shi, Q., Alberts, S.R., Smyrk, T.C., Sinicrope, F.A.

Volltext

Association of tumor-infiltrating lymphocytes with survival depends on primary tumor sidedness in stage III colon cancers (NCCTG N0147) [Alliance] von Saberzadeh-Ardestani, B., Foster, N.R., Lee, H.E., Shi, Q., Alberts, S.R., Smyrk, T.C., Sinicrope, F.A.

Volltext

Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled anal... von Taieb, J., Sinicrope, F.A., Pederson, L., Lonardi, S., Alberts, S.R., George, T.J., Yothers, G., Van Cutsem, E., Saltz, L., Ogino, S., Kerr, R., Yoshino, T., Goldberg, R.M., André, T., Laurent-Puig, P., Shi, Q.

Volltext

DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy von SINICROPE, Frank A, FOSTER, Nathan R, SARGENT, Daniel J, THIBODEAU, Stephen N, MARSONI, Silvia, MONGES, Genevieve, LABIANCA, Roberto, YOTHERS, Greg, ALLEGRA, Carmen, MOORE, Malcolm J, GALLINGER, Steven

Volltext

MiR-320e is a novel prognostic biomarker in colorectal cancer von Perez-Carbonell, L, Sinicrope, F A, Alberts, S R, Oberg, A L, Balaguer, F, Castells, A, Boland, C R, Goel, A

Volltext

Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status von Rego, R L, Foster, N R, Smyrk, T C, Le, M, O'Connell, M J, Sargent, D J, Windschitl, H, Sinicrope, F A

Volltext

Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines : Growth inhibition by nonsteroidal anti-inflammatory drugs von MOLINA, M. A, SITJA-ARNAU, M, LEMOINE, M. G, FRAZIER, M. L, SINICROPE, F. A

Volltext

The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions von Lanzi, Anastasia, Sinicrope, F. A., Benson, A. B., Galon, Jérôme

Volltext

MiR-320e is a novel prognostic biomarker in colorectal cancer von Perez-Carbonell, L, Sinicrope, F A, Alberts, S R, Oberg, A L, Balaguer, F, Castells, A, Boland, C R, Goel, A

Volltext

Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumors von TOYOTA, M, SHEN, L, OHE-TOYOTA, M, HAMILTON, S. R, SINICROPE, F. A, ISSA, J.-P. J

Volltext

Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers von Sinicrope, Frank A., Lemoine, Michael, Xi, Lixuan, Lynch, Patrick M., Cleary, Karen R., Shen, Yu, Frazier, Marsha L.

Volltext

bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis von SINICROPE, F. A, SAN BAO RUAN, CLEARY, K. R, STEPHENS, L. C, LEE, J. J, LEVIN, B

Volltext

Apoptotic and Mitotic Indices Predict Survival Rates in Lymph Node-negative Colon Carcinomas von SINICROPE, F. A, HART, J, HSU, H.-A, LEMOINE, M, MICHELASSI, F, STEPHENS, L. C

Volltext

HER‐2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumors von Half, Elizabeth, Broaddus, Russell, Danenberg, Kathleen D., Danenberg, Peter V., Ayers, Gregory D., Sinicrope, Frank A.

Volltext

P-142 Completion of genetic testing and incidence of pathogenic germline mutation among patients with early-onset colorectal cancer, a single institution retrospective analysis von Storandt, M., Rogen, K., Iyyangar, A., Mitchell, J., Hubbard, J., Sinicrope, F., Jatoi, A., Mahipal, A., Shi, Q., Jin, Z.

Volltext

Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma von SINICROPE, F. A, HART, J, MICHELASSI, F, LEE, J. J

Volltext

Increased apoptosis accompanies neoplastic development in the human colorectum von SINICROPE, F. A, RODDEY, G, MCDONNELL, T. J, SHEN, Y, CLEARY, K. R, CLIFTON STEPHENS, L

Volltext

Low Overexpression of HER-2/PPPNeu in Advanced Colorectal Cancer Limits the Usefulness of Trastuzumab (Herceptin registered ) and Irinotecan as Therapy. A Phase II Trial von Ramanathan, R K, Hwang, J J, Zamboni, W C, Sinicrope, F A, Safran, H, Wong, M K, Earle, M, Brufsky, A, Evans, T, Troetschel, M, Walko, C, Day, R, Chen, H X, Finkelstein, S

Volltext